The Technical Analyst
Select Language :
M3, Inc. [MTHRY]

Exchange: OTC Sector: Healthcare Industry: Health Information Services

M3, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals

M3, Inc. is listed at the  Exchange

2.09% $5.35

America/New_York / 3 mai 2024 @ 15:59


FUNDAMENTALS
MarketCap: 7 265.50 mill
EPS: 0.210
P/E: 25.48
Earnings Date: Jun 26, 2024
SharesOutstanding: 1 358.04 mill
Avg Daily Volume: 0.143 mill
RATING 2024-05-03
A
Buy
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Buy
Return On Asset: Buy
DE: Neutral
P/E: Buy
Price To Book: Neutral
QUARTER GROWTHS
4/221/232/233/234/231/24
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.88x
Company: PE 25.48 | sector: PE 29.05
PE RATIO: COMPANY / INDUSTRY
0.46x
Company: PE 25.48 | industry: PE 55.39
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 5.12 - 5.58

( +/- 4.30%)
ATR Model: 14 days

Forecast: 16:00 - $5.35

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $5.35
Forecast 2: 16:00 - $5.35
Forecast 3: 16:00 - $5.35
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $5.35 (2.09% )
Volume 0.0414 mill
Avg. Vol. 0.143 mill
% of Avg. Vol 28.93 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for M3, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for M3, Inc.

RSI

Intraday RSI14 chart for M3, Inc.

Last 10 Buy & Sell Signals For MTHRY

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            M3, Inc.

MTHRY

M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates through five reporting segments: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. It operates m3.com, a members-only Web site for providing information to the healthcare professionals; MR-kun, where member doctors can independently and continuously receive information on the m3com platform; QOL-kun that provides life support information other than medical information to members; AskDoctors, where registered doctors answer questions about health and illness from the general public; MDLinx for medical professionals in the United States; and Doctorsnetuk, a website that provides developing services for pharmaceutical companies, as well as provides drug information database in France, Germany, and Spain. The company also provides career services for doctors and pharmacists through m3com CAREER. In addition, it engages in the sales activities and marketing operations for pharmaceuticals and medical devices; development, sale, and support business of electronic medical records and medical equipment for medical institutions; survey service for medical professionals; sale and marketing support businesses for pharmaceutical companies, etc. through the Internet; provision of management support and consulting services to medical institutions, and home-visit nursing services; and provision of human resources services for healthcare professionals, as well as operates clinical trial facilities. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.

Last 10 Buy Signals

Date Signal @
RTYUSDMay 6 - 00:572 051.20
BRRRUSDMay 6 - 00:211 609.77
SILUSDMay 6 - 00:4427.09
CUSDUSDMay 6 - 00:500.999
NQUSDMay 6 - 00:3617 998
HBARUSDMay 6 - 00:44$0.114
SIUSDMay 6 - 00:44$27.10
GOHMUSDMay 6 - 00:423 283.12
FRONTUSDMay 6 - 00:40$1.140
COREUSDMay 6 - 00:356 105.94

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.